Showing results (331-340 of 1,400) with videos related to
Sort By:
Pageof 140
Pharmacology Research & Perspectives|July 15, 2015
Pharmacokinetic study of metopimazine by oral route in childrenEric Mallet, Frederic Bounoure, Mohamed Skiba, et al.Pharmacology Research & Perspectives|July 15, 2015
Antidepressant activity of fingolimod in miceLuigi di Nuzzo, Rosamaria Orlando, Cristina Tognoli, et al.Pharmacology Research & Perspectives|July 15, 2015
Simvastatin mitigates increases in risk factors for and the occurrence of cardiac disease following 10 Gy total body irradiationMarek Lenarczyk, Jidong Su, Steven T Haworth, et al.Pharmacology Research & Perspectives|July 15, 2015
Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cellsJohnny X Huang, Geraldine Kaeslin, Max V Ranall, et al.Pharmacology Research & Perspectives|July 15, 2015
Analysis of drug combinations: current methodological landscapeJulie Foucquier, Mickael GuedjPharmacology Research & Perspectives|July 15, 2015
Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidatesYihui Shi, Amanda S Joyner, William Shadrick, et al.Pharmacology Research & Perspectives|February 9, 2018
Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimensNatalia V Ortiz Zacarías, Anneke C Dijkmans, Jacobus Burggraaf, et al.Pharmacology Research & Perspectives|December 12, 2017
Distortion of KB estimates of endothelin-1 ETA and ETB receptor antagonists in pulmonary arteries: Possible role of an endothelin-1 clearance mechanismJames A Angus, Richard J A Hughes, Christine E WrightPharmacology Research & Perspectives|December 12, 2017
Modeling of prolactin response following dopamine D2 receptor antagonists in rats: can it be translated to clinical dosing?Amit Taneja, An Vermeulen, Dymphy R H Huntjens, et al.Pharmacology Research & Perspectives|October 4, 2017
Pharmacological hypothesis: Nitric oxide-induced inhibition of ADAM-17 activity as well as vesicle release can in turn prevent the production of soluble endothelin-converting enzymeSanjaya Kuruppu, Niwanthi W Rajapakse, Helena C Parkington, et al.Pageof 140